Atrogi, a pioneering clinical-stage biotech company advancing treatments for metabolic disorders, announces the full set of results from its Phase...
Recce Pharmaceuticals Ltd (ASX: RCE, FSE: R9Q), (the Company), the Company developing a new class of synthetic anti-infectives, today announced...
Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) today announced that it has commenced sales of its second...
Jivamrit Organic, a pioneer in the organic food sector, is poised to revolutionize the culinary scene with the introduction of...
Today, Cedar Health Research®, a multi-therapeutic independent clinical research site and patient network, officially announced two new sites in Texas located in Arlington,...
Physicians Lab, a provider of at-home lab testing for integrative medicine and wellness, launched a new at-home lab test that...
Today, Family Research Council (FRC), together with Dr. Michael New, Assistant Professor of Social Research at the Busch School of Business...
Cureskin, an AI-driven dermatology platform that provides clinically validated skin & hair health solutions, has raised Series B funding of...
Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and...
Bavarian Nordic A/S (OMX: BAVA) announced today that the Swiss Agency for Therapeutic Products, Swissmedic, has approved JYNNEOS® (MVA-BN) for active...
